MedTrace Logo

Effects of Pharmacist-led Medication Reconciliation Services on Geriatric Patients

NCT06610292 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2024-09-24

No results posted yet for this study

Summary

This study aims to assess the effects of Pharmacist-led medication reconciliation on hospitalized elderly patients aged above 65 at a leading tertiary military hospital in Jordan.

Conditions

  • Geriatric Patients
  • Medication Reconcilitation Upon Hospital Admission
  • Medication Reconciliation At Discharge
  • Pharmacist-led Medication Reconciliation

Interventions

OTHER

Pharmacist-led medication reconciliation services

Upon admission, information about patients Best Possible Medication History (BPMH) was extracted. Information on current medications, both regular and as-needed, was also recorded. All data were cross-referenced with the electronic records and verified through patients or caregivers interviews to create a comprehensive medication list. Then, comparison was conducted between standard care medication list and Pharmacist-led medication reconciliation list to identify any possible medication discrepancies. Also, during hospital stay and upon discharge emerging medication discrepancies were assessed and resolved. Moreover, the impacts on healthcare resources utilization within 30 days post-discharge was measured. This includes evaluating hospital re-admissions, emergency department visits, and the occurrence of any adverse drug events (ADEs).

Sponsors & Collaborators

  • Jordanian Royal Medical Services

    collaborator OTHER

  • Royal Medical Services, Jordanian Armed Forces

    collaborator OTHER

  • University of Jordan

    lead OTHER

Principal Investigators

  • Eman A Hammad · Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-24
Primary Completion
2018-10-13
Completion
2018-10-13

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06610292 on ClinicalTrials.gov